Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00413673 · ClinicalTrials.gov registry record · NA

Initial Evaluation of Photorefractive Keratectomy in U.S. Army Personnel

A NA study, sponsored by Walter Reed Army Medical Center.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT00413673: Completed NA study, sponsored by Walter Reed Army Medical Center.

NCT00413673 is a NA study that has completed, run by Walter Reed Army Medical Center. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00413673, a NA study, has completed, sponsored by Walter Reed Army Medical Center.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The objective of this study is to conduct a prospective clinical trial to evaluate the safety and efficacy fo the VISX Excimer Laser system for the treatment of naturally occurring low to moderate myopia, with or without low levels of astigmatism, in U.S. Army personnel.

Interventions

  • PROCEDURE PRK

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2001-08
Est. Completion 2008-03
Phase NA
Walter Reed Army Medical Center

24 total trials

What the finished NCT00413673 record still lists

NCT00413673 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which PRK is the first listed.

NCT00413673 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00413673 about?

NCT00413673 is a clinical study titled "Initial Evaluation of Photorefractive Keratectomy in U.S. Army Personnel". The objective of this study is to conduct a prospective clinical trial to evaluate the safety and efficacy fo the VISX Excimer Laser system for the treatment of naturally occurring low to moderate myopia, with or without low levels of astigmatism, in U.S. Army personnel.

What is the current status of trial NCT00413673?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2001-08. Estimated completion is 2008-03.

What interventions are being tested in trial NCT00413673?

The interventions under investigation include: PRK (PROCEDURE).

Who is sponsoring clinical trial NCT00413673?

This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00413673's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00413673, the US trial registry maintained by the National Library of Medicine. NCT00413673 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.